Publications found:
194
Sort by:
Genital Herpes Treatment Market - 2024-2031
US$ 3,400.00
Genital Herpes Treatment Market reached US$ 1,143.19 million in 2023 and is expected to reach US$ 1,669.81 million by 2031, growing with a CAGR of 4.80% during the forecast period 2026-2031. The Genit...
August 2024
50 pages
Bacterial Pharyngitis Drugs Market - 2024-2031
US$ 3,400.00
Bacterial Pharyngitis Drugs Market reached US$ 2.5 billion in 2023 and is expected to reach US$ 3.6 billion by 2031, growing with a CAGR of 4.80% during the forecast period 2026-2031. The Bacterial Ph...
June 2024
53 pages
H3N2 Infection Drugs Market - 2024-2031
US$ 3,400.00
The H3N2 Infection Drugs Market emerges as a key focus in DataM Intelligence latest in-depth analysis, where seasoned researchers harness advanced data analytics and strategic foresight to deliver unp...
June 2024
46 pages
Invasive Pneumococcal Disease Market - 2024-2031
US$ 3,400.00
The Invasive Pneumococcal Disease Market emerges as a key focus in DataM Intelligence latest in-depth analysis, where seasoned researchers harness advanced data analytics and strategic foresight to de...
June 2024
55 pages
Hospital Infection Therapeutics Market - 2024-2031
US$ 3,400.00
Hospital Infection Therapeutics Marketis is growing with a CAGR of 2.60% during the forecast period 2026-2035. The Hospital Infection Therapeutics Market emerges as a key focus in DataM Intelligence l...
April 2024
57 pages
Herpes Simplex Virus Treatment Market Report by Type (Herpes Simples Virus-1 Infection, Herpes Simplex Virus-2 Infection, and Others), Drug Type (Acyclovir, Valacyclovir, Famciclovir, and Others), Route of Administration (Oral, Injectable, Topical), Distribution Channel (Hospital Pharmacy, Drug Stores, Retail Stores, Online Pharmacy), and Region 2024-2032
US$ 2,999.00
The global herpes simplex virus treatment market size reached US$ 2.6 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 4.0 Billion by 2032, exhibiting a growth rate (CAGR)...
April 2024
137 pages
Bacterial Pneumonia Market - 2024-2031
US$ 3,400.00
Bacterial Pneumonia Market reached US$ 2.7 billion in 2022 and is expected to reach US$ 5.0 billion by 2031, growing with a CAGR of 8.10% during the forecast period 2026-2031. The Bacterial Pneumonia...
February 2024
45 pages
MRSA Drugs Market by MRSA Type (Hospital-Acquired (HA-MRSA), Community-Acquired (CA-MRSA)), Drug Class (Lipopeptides, Oxazolidinones, Cephalosporin, Tetracycline, Folate Antagonist, and Others), Disease Indication (Skin Infections, Bone and Joint Infections, Bacteremia, Animal Infections), Route of Administration (Oral Administration, Parenteral Administration), Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), and Region 2024-2032
US$ 2,999.00
The global MRSA drugs market size reached US$ 3.8 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 5.0 Billion by 2032, exhibiting a growth rate (CAGR) of 3.11% during 202...
January 2024
149 pages
Herpes Simplex Virus Treatment Market - 2024-2031
US$ 3,400.00
The Herpes Simplex Virus Treatment Market emerges as a key focus in DataM Intelligence latest in-depth analysis, where seasoned researchers harness advanced data analytics and strategic foresight to d...
January 2024
56 pages
Traveler's Diarrhea Market - 2024-2031
US$ 3,400.00
The Traveler's Diarrhea Market emerges as a key focus in DataM Intelligence latest in-depth analysis, where seasoned researchers harness advanced data analytics and strategic foresight to deliver unpa...
January 2024
45 pages
Dengue Vaccine Market - 2024-2031
US$ 3,400.00
Dengue Vaccine Marketis is growing with a CAGR of 10.40% during the forecast period 2026-2035. The Dengue Vaccine Market emerges as a key focus in DataM Intelligence latest in-depth analysis, where se...
January 2024
40 pages
Zika Virus Therapeutics Market - 2024-2031
US$ 3,400.00
The Zika Virus Therapeutics Market emerges as a key focus in DataM Intelligence latest in-depth analysis, where seasoned researchers harness advanced data analytics and strategic foresight to deliver...
January 2024
49 pages
HIV-associated Lipodystrophy Market - 2024-2031
US$ 3,400.00
HIV-associated Lipodystrophy Marketis is growing with a CAGR of 3.40% during the forecast period 2026-2035. The HIV-associated Lipodystrophy Market emerges as a key focus in DataM Intelligence latest...
December 2023
54 pages
Herpes Zoster Oticus Market - 2024-2031
US$ 3,400.00
The Herpes Zoster Oticus Market emerges as a key focus in DataM Intelligence latest in-depth analysis, where seasoned researchers harness advanced data analytics and strategic foresight to deliver unp...
November 2023
47 pages
Group B Streptococcus (GBS) Market - 2024-2031
US$ 3,400.00
The Group B Streptococcus (GBS) Market emerges as a key focus in DataM Intelligence latest in-depth analysis, where seasoned researchers harness advanced data analytics and strategic foresight to deli...
November 2023
53 pages
Herpes Zoster Infection Treatment Market - 2024-2031
US$ 3,400.00
Herpes Zoster Infection Treatment Marketis is growing with a CAGR of 3.60% during the forecast period 2026-2035. The Herpes Zoster Infection Treatment Market emerges as a key focus in DataM Intelligen...
September 2023
59 pages
Shigella Infections Market - 2024-2031
US$ 3,400.00
The Shigella Infections Market emerges as a key focus in DataM Intelligence latest in-depth analysis, where seasoned researchers harness advanced data analytics and strategic foresight to deliver unpa...
September 2023
45 pages
Listeriosis Market - 2024-2031
US$ 3,400.00
The Listeriosis Market emerges as a key focus in DataM Intelligence latest in-depth analysis, where seasoned researchers harness advanced data analytics and strategic foresight to deliver unparalleled...
September 2023
37 pages
Invasive Fungal Infection Market - 2024-2031
US$ 3,400.00
The Invasive Fungal Infection Market emerges as a key focus in DataM Intelligence latest in-depth analysis, where seasoned researchers harness advanced data analytics and strategic foresight to delive...
April 2023
51 pages